| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 215,573 | 220,330 | ||
| Marketable securities, current | 70,205 | 76,965 | ||
| Accounts receivable | 515 | 603 | ||
| Prepaid expenses and other current assets | 4,535 | 3,799 | ||
| Total current assets | 290,828 | 301,697 | ||
| Investments | 100 | 100 | ||
| Marketable securities | 10,078 | 16,108 | ||
| Property and equipment, gross | 1,386 | - | ||
| Accumulated depreciation | 413 | - | ||
| Property and equipment, net | 973 | 974 | ||
| Operating lease right-of-use assets, net | 2,884 | 3,032 | ||
| Other assets | 227 | 237 | ||
| Total assets | 305,090 | 322,148 | ||
| Accounts payable | 5,018 | 1,329 | ||
| Accrued expenses and other current liabilities | 7,263 | 7,584 | ||
| Principal loan balance | 3,500 | - | ||
| Final fee | 633 | - | ||
| Unamortized debt discount | 7 | - | ||
| Term loan, current | 4,126 | 5,596 | ||
| Operating lease liabilities, current | 580 | 630 | ||
| Deferred revenue, current | 7,506 | 7,698 | ||
| Total current liabilities | 24,493 | 22,837 | ||
| Deferred revenue | 556 | 1,902 | ||
| Term loan | 0 | 0 | ||
| Warrant liability | 150 | 108 | ||
| Operating lease liabilities | 2,427 | 2,520 | ||
| Total liabilities | 27,626 | 27,367 | ||
| Additional paid-in-capital | 584,662 | 581,871 | ||
| Accumulated other comprehensive income | 275 | 212 | ||
| Accumulated deficit | -307,473 | -287,302 | ||
| Total stockholders' equity | 277,464 | 294,781 | ||
| Total liabilities and stockholders' equity | 305,090 | 322,148 | ||
BioAge Labs, Inc. (BIOA)
BioAge Labs, Inc. (BIOA)